# Pharmacokinetics of Levofloxacin in Intensive Care Unit

> **NCT02018081** · PHASE4 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 52 (actual)

## Conditions studied

- Intensive Care Unit Syndrome
- Community-acquired Pneumonia

## Interventions

- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT02018081
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2015-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018081, "Pharmacokinetics of Levofloxacin in Intensive Care Unit". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02018081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*